Net Sales are expected to increase by 2.1 percent Y-o-Y (down 7.2 percent Q-o-Q) to Rs. 4,061 crore, according to Prabhudas Lilladher.
Prabhudas Lilladher has come out with its fourth quarter (January-March’ 19) earnings estimates for the Pharma sector. The brokerage house expects Lupin to report net profit at Rs. 253.2 crore down 62.8% year-on-year (up 32.9% quarter-on-quarter).
Net Sales are expected to increase by 2.1 percent Y-o-Y (down 7.2 percent Q-o-Q) to Rs. 4,061 crore, according to Prabhudas Lilladher.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 14.3 percent Y-o-Y (down 10.5 percent Q-o-Q) to Rs. 560.1 crore.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Read More
